Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Nefiracetam for post-stroke apathy
ACTRN12609000975291Phase 2Completed
- Sponsor
- Fremantle Hospital and Health Service
- Start
- Jul 2010
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2, randomised, double-blind trial of nefiracetam in stroke and apathy, sponsored by Fremantle Hospital and Health Service. Primary endpoint: Apathy Scale at week 36. Started Jul 2010; status: completed.
02
Drugs
nefiracetam
03
Conditions
strokeapathy
Beyond the preview
Go deeper on ACTRN12609000975291.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ACTRN12609000975291.